Stevenage, United Kingdom

Rita Field

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rita Field. Retrieved from https://idiyas.com/inventor/rita-field

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rita Field: Innovator in Respiratory Therapeutics

Introduction

Rita Field is a notable inventor based in Stevenage, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target respiratory diseases. Her work has led to the filing of a patent that showcases her innovative approach to therapy.

Latest Patents

Rita Field holds a patent for "Formailide derivatives as beta2-adrenoreceptor agonists." This invention relates to novel compounds of formula (I), a process for their manufacture, pharmaceutical compositions containing them, and their therapeutic use, especially in the prophylaxis and treatment of respiratory diseases. She has 1 patent to her name, reflecting her commitment to advancing medical science.

Career Highlights

Throughout her career, Rita has been associated with Glaxo Group Limited, a leading pharmaceutical company. Her work there has allowed her to focus on innovative solutions for respiratory health, contributing to the development of effective treatments.

Collaborations

Rita has collaborated with esteemed colleagues, including Keith Biggadike and Stephen Barry Guntrip. These partnerships have enhanced her research and development efforts, leading to impactful advancements in the pharmaceutical industry.

Conclusion

Rita Field's contributions to respiratory therapeutics exemplify her dedication to innovation in medicine. Her patent and collaborations highlight her role as a key figure in the development of new treatments for respiratory diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…